Latest filing published 15 Nov 2023 for RESMED INC, €18k.
Insider track record
Lucile Blaise: trading record in brief
Lucile Blaise is a declared insider of ResMed Inc, with filings sourced from SEC (Form 4). Between 15 November 2022 and 13 November 2023, the trades on record add up to 10 filings.
No open-market purchase appears, only 1 sale worth €37k. Besides market trades, the filings include 8 share grants and 1 option exercise.
On 15 November 2023 came the latest disclosure, a share grant for €18k in ResMed Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lucile Blaise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 135.354 shares@ US$143.606.4% of flowResMed Common StockSEC:0001127602-23-027461:0
- 379.689 shares@ US$165.6720.5% of flowResMed Common StockSEC:0001127602-23-023392:0
- 819 shares0ResMed Common StockSEC:0001127602-23-022931:0
- 114 shares@ US$224.408.7% of flowResMed Common StockSEC:0001127602-22-026264:0
- 78 shares@ US$224.406.0% of flowResMed Common StockSEC:0001127602-22-026264:1
- 75 shares@ US$224.405.7% of flowResMed Common StockSEC:0001127602-22-026264:2
- 169 shares@ US$225.1813.0% of flowResMed Common StockSEC:0001127602-22-026089:0
- 516 shares@ US$225.1839.7% of flowResMed Common StockSEC:0001127602-22-025844:0
8 of 8 declarations
